Danish experts now fear that more pharma companies will withdraw medicines from Denmark to avoid being penalised in the US market ...
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2026年3月3日星期二,默沙东集团(NYSE:MRK)在TD Cowen第46届年度医疗保健大会上发表演讲,公布了其战略举措,以缓解其重磅药物KEYTRUDA失去专利独占权后预期的收入影响。该公司强调其专注于创新、多元化和战略性业务发展,同时承认未来面临的挑战和机遇。 MK-3000针对对抗VEGF疗法无反应的糖尿病性黄斑水肿和新生血管性AMD患者。 用于HIV的Islatravir/Lenac ...
Former Vertex executive to spearhead the clinical development of Absci's expanding AI-designed therapeutics pipeline Chief Innovation Officer Andreas Busch to retire March 31, 2026 and will continue ...
Amgen (NASDAQ:AMGN) executives highlighted broad-based commercial momentum, a focus on long-term growth drivers, and several ...
2026年3月2日星期一,安进公司 (NASDAQ:AMGN)在TD Cowen第46届年度医疗保健会议上进行了展示。该公司强调了其2025年的强劲表现,主要得益于关键产品的强劲增长,同时也提到了2026年可能面临的挑战,包括市场动态和竞争压力。
TD Cowen 46th Annual Health Care Conference March 2, 2026 1:10 PM ESTCompany ParticipantsKave Niksefat - Senior Vice President of ...
Zacks Investment Research on MSN
Why Amgen (AMGN) is a top value stock for the long term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Amgen Inc. (NASDAQ:AMGN) is included among the 13 Best NASDAQ Dividend Stocks to Buy Now. On February 20, Barclays initiated coverage of Amgen Inc. (NASDAQ:AMGN) with an Equal Weight rating and a $185 ...
Q. I developed severe depression while taking Repatha, the injectable cholesterol-lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...
Most Medicare drug plans cover Repatha (evolocumab). This includes stand-alone Part D prescription drug plans and Medicare Advantage plans that include prescription drug coverage. Doctors prescribe ...
Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% for at-risk patients who have never had a heart attack or stroke, according to results from a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果